PDVAC Executive summary 2018: 5th annual meeting

The Doha Room at the Starling Hotel, Geneva, Switzerland, 26-27 June 2018

30 June 2018
 | Meeting report
Download (377.6 kB)

Overview

On 26–28 June, WHO’s Product Development for Vaccines Advisory Committee (PDVAC) was convened for its 5th annual meeting. Progress was discussed in vaccine and monoclonal antibody (mAb) development for the 10 previously prioritized pathogen areas and also for 3 new pathogens with candidates in, or approaching, clinical development. Several cross-cutting topics were considered and two new vaccine product development initiatives were presented. 

 

WHO Team
Immunization, Vaccines and Biologicals (IVB)
Editors
Product Development for Vaccines Advisory Committee (PDVAC)
Number of pages
8